News • Immunology
Researchers discover new type of anticancer T-cell
A molecule called MR1 (MHC Class I-related Molecule 1) enables a newly-discovered type of T-cells to sense differences in the metabolism that occur when cells become cancerous.
Cancer
News • Ultrasound-based lesion detection
Ovarian cancer diagnosis improved by AI
Ovarian cancer is common and often only detected by chance. A newly developed AI-based model could help differentiate between benign and malignant ovarian lesions.
News • Driving mechanism identified
Why the lung is a frequent site of cancer metastasis
More than half of cancer patients in whom the cancer spreads beyond the primary site have lung metastases. What makes the lungs such a tempting place for cancer cells? New research may have an answer.
News • Research into new therapies
How natural killer cells could fight leukemia more effectively
Researchers now succeeded in making leukemia-specific immune cells less sensitive to the influence of tumor cells, thereby significantly increasing their effectiveness.
News • PET compound
New radiotracer lights up aggressive cancer tumours
A new radiotracer – an injected compound used in PET scans – could help inform doctors that a patients aggressive cancer will not respond to chemotherapy before treatment is given.
News • DTI reveals intraepithelial neoplasia
Detecting pre-malignant pancreatic lesions with diffusion tensor MRI
In a new study, researchers have shown, for the first time, that a particular form of MRI, called diffusion tensor imaging, is capable of robustly detecting pre-malignant lesions in the pancreas.
News • Human papillomavirus infection
Cervical cancer: improved screening through HPV risk groups
Analyses of self-tests for human papillomavirus (HPV) can be used to divide HPV-positive women into three risk groups, according to a new study. This could enhance cervical cancer screening.
News • Cancer development research
Exploring the role of sex in tumor growth
Tumors in female fruit flies grow significantly larger than in male ones, a new study finds. The findings could lead to a better understanding of how the biological sex impacts cancer development.
News • Reduction of severe side-effects
A 'kinder' chemotherapy for Hodgkin lymphoma
Treating patients with Hodgkin lymphoma with a different form of chemotherapy shows promise to reduce severe side effects, shorten hospital time and increase likelihood of recovering fertility.
News • New approach to combat treatment resistance
How chemotherapy affects ovarian cancer tumours
Research offers new insights into harnessing the immune system to combat ovarian cancer. The findings could lead to personalized therapies that target the right patients at the right time.
Sponsored • Collaboration in pathology
MEDIPATH makes a step towards lab automation with the help of Sakura Finetek Europe
Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management. This decision is part of an ongoing commitment to improving the quality of care provided to patients and in response to the significant increase in cancer cases over the last years.
News • Hyperpolarised carbon-13 imaging
Metabolic MRI imaging distinguishes ovarian cancer subtypes
A new MRI-based imaging technique predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Article • AI-assisted image analysis
More accuracy in brain tumour segmentation
Precise segmentation of anatomical structures greatly benefits cancer diagnosis. Using AI and deep learning methods, researchers are developing a high-precision 3D viewer software for medical image data.
News • Tumour movement across tissues
Understanding metastasis: migration strategies of ovarian cancer
A new study shows how inherent variations in a cancer cell and its interactions with its surroundings mould its migration. The findings provide valuable insights into the processes behind metastasis.
News • New therapy approach for brain tumors
Attacking glioblastoma from multiple angles
A new approach to fight glioblastoma: Swiss researchers have now developed an immunotherapy that not only attacks the brain tumor—it also turns its microenvironment against it.
News • Incidentaloma detection
Liquid biopsy as diagnostic tool for pancreatic lesions
New research highlights the potential of liquid biopsy in diagnosing pancreatic incidentaloma - lesions which can occasionally signal pancreatic cancer in its earliest stages.
News • Microgravity-induced changes
How cancer cell cultures in space can help defeat cancer on Earth
New insights gained from 3D cell cultures of breast and prostate cancer grown on the International Space Station (ISS) National Laboratory could lead to a way to treat not just these but all cancers.
News • Research on "double strike" mechanism
Induction of defective cell division could improve blood cancer therapy
Tumor cells are notorious for their rapid and uncontrolled division, and many cancer therapies aim to disrupt this. New findings suggest potential applications of apoptosis in blood cancer treatment.
News • Catch some EVs
Liquid biopsy to improve cancer diagnosis
A new method could open new avenues to quick, affordable cancer diagnosis, US researchers report. The method uses ultrathin membranes to capture extracellular vesicles.
Video • Cancer research
3D-printed tumor model reveals metastasis mechanisms
New insights into metastasis: Scientists created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. This could help discover new screening and treatment options.
Interview • Congress showcases advances
Making immunotherapy work for more cancer patients
Immunotherapy has become the most promising strategy for treating several cancers, but its effectiveness is still very uneven. Three researchers explain how research is being done to change this.
News • Cancer treatment advances
USC study findings: early blood test forecasts survival rates in patients with metastatic prostate cancer
A new study found that measuring circulating tumor cells (CTCs), rare cancer cells shed from tumors into the blood, is a reliable way to predict later treatment response and survival prospects with metastatic prostate cancer.
News • Brain cancer immunotherapy
Turning immune cells against glioblastomas
Scientists at the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue.
News • Hematology
Using AI to predict multiple myeloma evolution
Researchers have succeeded in identifying patterns of response to treatment in patients with multiple myeloma using AI tools, which helps to accurately predict the evolution of the tumor.
News • Hard to treat cancers
KRAS “degrader” could lead to treatment for millions of cancer patients
A newfound molecule, called ACBI3, could potentially lead to new therapies against hard-to-treat cancers, improving outcomes for all patients with cancers caused by KRAS mutations.